Cleared Traditional

K002265 - BRANAN MEDICAL CORPORATION MONITECT MET...

K002265 is the FDA 510(k) clearance for BRANAN MEDICAL CORPORATION MONITECT MET... by Branan Medical Corporation. It is a Class 2 Toxicology device (product code DJC) cleared through the Traditional 510(k) pathway after a 125-day FDA review.

K002265 · Branan Medical Corporation · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
125d
Days
Class 2
Risk

K002265 is an FDA 510(k) clearance for the BRANAN MEDICAL CORPORATION MONITECT METHAMPHETAMINE DRUG SCREEN TEST. Classified as Thin Layer Chromatography, Methamphetamine (product code DJC), Class II - Special Controls.

Submitted by Branan Medical Corporation (Irvine, US). The FDA issued a Cleared decision on November 27, 2000 after a review of 125 days - within the typical 510(k) review window.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3610 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Branan Medical Corporation devices

Submission Details

510(k) Number K002265 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2000
Decision Date November 27, 2000
Days to Decision 125 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 87d · This submission: 125d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DJC Thin Layer Chromatography, Methamphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3610
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DJC Thin Layer Chromatography, Methamphetamine

All 15
Devices cleared under the same product code (DJC) and FDA review panel - the closest regulatory comparables to K002265.
OralTox Oral Fluid Drug Test
K171403 · Premier Biotech, Inc. · Feb 2018
WONDFO OXAZEPAM URINE TEST (BZO 200) AND WONDFO METHAMPHETAMINE URINE TEST (MET 300)
K132630 · Guangzhou Wondfo Biotech Co., Ltd. · Sep 2013
INSTANT-VIEW MDMA (ECSTASY, XTC) URINE TEST
K022501 · Alfa Scientific Designs, Inc. · Nov 2002
INSTANT-VIEW METHAMPHETAMINE URINE DIP STRIP TEST
K994406 · Alfa Scientific Designs, Inc. · Aug 2000
INSTANT-VIEW METHAMPHETAMINE URINE CASSETTE TEST
K994400 · Alfa Scientific Designs, Inc. · Aug 2000
ONTRAK TESTCUP PRO-5, MODEL 1986678
K001356 · Roche Diagnostics Corp. · Jul 2000